Concord Biotech Limited

CONCORDBIO

Quarterly results

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Sept 2026312

    Quarter₹ croreYoY
    Sept 2024310+18.2%
    Dec 2024244+1.4%
    Mar 2025430+34.8%
    Jun 2025204-5.5%
    Sept 2025247-20.4%
    Dec 2025278+13.9%
    Mar 2026326-24.2%
    Jun 2026261+27.7%
    Sept 2026312+26.4%
  • ₹ crore

    Sept 202610

    Quarter₹ crore
    Sept 202410
    Dec 202415
    Mar 20259
    Jun 202514
    Sept 202513
    Dec 202510
    Mar 202616
    Jun 202613
    Sept 202610
  • ₹ crore

    Sept 2026323

    Quarter₹ crore
    Sept 2024320
    Dec 2024259
    Mar 2025439
    Jun 2025218
    Sept 2025260
    Dec 2025288
    Mar 2026341
    Jun 2026274
    Sept 2026323
  • Cost structure
  • ₹ crore

    Sept 202649

    Quarter₹ crore
    Sept 202434
    Dec 202435
    Mar 202539
    Jun 202538
    Sept 202543
    Dec 202544
    Mar 202645
    Jun 202641
    Sept 202649
  • ₹ crore

    Sept 2026221

    Quarter₹ crore
    Sept 2024187
    Dec 2024160
    Mar 2025254
    Jun 2025160
    Sept 2025175
    Dec 2025195
    Mar 2026223
    Jun 2026191
    Sept 2026221
  • Exceptional items and tax
  • ₹ crore

    Sept 2026102

    Quarter₹ crore
    Sept 2024133
    Dec 202499
    Mar 2025185
    Jun 202557
    Sept 202586
    Dec 202590
    Mar 2026118
    Jun 202682
    Sept 2026102
  • ₹ crore

    Sept 202626

    Quarter₹ crore
    Sept 202435
    Dec 202425
    Mar 202543
    Jun 202515
    Sept 202523
    Dec 202523
    Mar 202628
    Jun 202621
    Sept 202626
  • Profit
  • ₹ crore

    Sept 202676

    Quarter₹ croreYoY
    Sept 202499+16.8%
    Dec 202474-0.6%
    Mar 2025142+46.0%
    Jun 202543-26.9%
    Sept 202563-36.3%
    Dec 202568-8.5%
    Mar 202690-36.6%
    Jun 202661+43.8%
    Sept 202676+20.4%
  • Per share
  • ₹ per share

    Sept 20267.24

    Quarter₹ per share
    Sept 20249.43
    Dec 20247.08
    Mar 202513.57
    Jun 20254.07
    Sept 20256.01
    Dec 20256.48
    Mar 20268.60
    Jun 20265.85
    Sept 20267.24
₹ croreSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Income
310244430204247278326261312
Revenue YoY+18.2%+1.4%+34.8%-5.5%-20.4%+13.9%-24.2%+27.7%+26.4%
10159141310161310
320259439218260288341274323
Cost structure
343539384344454149
187160254160175195223191221
Exceptional items and tax
1339918557869011882102
352543152323282126
Profit
9974142436368906176
Net profit YoY+16.8%-0.6%+46.0%-26.9%-36.3%-8.5%-36.6%+43.8%+20.4%
Per share
9.437.0813.574.076.016.488.605.857.24

Latest filed period ends Sept 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.